Skip to main content
Erschienen in: BMC Infectious Diseases 1/2018

Open Access 01.12.2018 | Case report

Case report: two confirmed cases of human Seoul virus infections in Indonesia

verfasst von: Khie Chen Lie, Mochamad Helmi Aziz, Herman Kosasih, Aaron Neal, Caleb Leonardo Halim, Wahyu Nawang Wulan, Muhammad Karyana, Usman Hadi

Erschienen in: BMC Infectious Diseases | Ausgabe 1/2018

Abstract

Background

Seoul virus (SEOV) is a member of hantavirus family, which is transmitted to humans by Rattus rattus and Rattus norvegicus. Diagnosing SEOV infection is difficult because the clinical presentations are often undifferentiated with other viral or bacterial infections and assays to test antibodies seroconversion and RNA detection are not available in resource-limited setting like Indonesia.

Case presentation

We report two confirmed cases of SEOV infection from Indonesia. Here, we illustrate the clinical presentations, hematology and biochemistry profiles, and outcomes of the two cases. Phylogenetic analysis revealed that SEOV sequences have highest homology to isolates obtained from rodents in Indonesia.

Conclusions

This report highlights the importance of considering SEOV infection in febrile patients with lymphopenia, thrombocytopenia, and elevation of liver enzyme despite the absence of hemorrhagic manifestations and renal syndromes. The public health importance of rodent-borne diseases such as SEOV infection urges an integrated epidemiological surveillance both in humans and rodents in Indonesia.
Hinweise

Electronic supplementary material

The online version of this article (https://​doi.​org/​10.​1186/​s12879-018-3482-1) contains supplementary material, which is available to authorized users.
Abkürzungen
AFIRE
Acute Febrile Illness Requiring Hospitalization
ALT
Alanine transaminase
AST
Aspartate transaminase
CMV
Cytomegalovirus
EDTA
Ethylenediaminetetraacetic acid
ELISA
Enzyme-linked immunosorbent assay
HFRS
Hemorrhagic fever with renal syndrome
HIV
Human Immunodeficiency virus
HSV
Herpes Simplex Virus
NIHRD
National Institute of Health and Research and Development
RNA
Ribonucleic acid
RT-PCR
Reverse transcriptase-polymerase chain reaction
SEOV
Seoul virus
SOC
Standard of care

Background

Seoul virus (SEOV) is a member of hantavirus family that is carried by the rodent vectors Rattus rattus and Rattus norvegicus [1]. Both rodents are widespread globally, thus making SEOV distribution worldwide [1] with confirmed human cases in Asia [25], Europe [68], and North America [9, 10]. The symptoms and signs of SEOV infection are not specific, including fever, headache, nausea, joint pain, cough, and a mild to moderate form of hemorrhagic fever with renal syndrome (HFRS) accompanied with elevation of liver enzyme [5, 10].
As these clinical presentations are undifferentiated with other infectious diseases, diagnosis can only be confirmed when IgM positive and/or rising IgG antibodies between acute and convalescent blood specimens and/or SEOV RNA in the acute specimen is detected [11]. Since the coated antigen in the commercial available antibody assay is a recombinant protein of all hantavirus species, the detected IgM/IgG antibodies are not specific to SEOV. In addition, antibody persistence could leads to false positivity, and this assay must be performed in batch to be cost-effective [11]. Molecular techniques, by SEOV RNA detection, may overcome the limitation of antibody detection, however, SEOV RNA is not detected after the acute phase. Due to the aforementioned reasons, SEOV infection in humans in Indonesia was rarely reported. Hantavirus infections based on the presence of IgM antibodies were found in Semarang [12] and Yogyakarta [13]. On the contrary, SEOV infection in rodents has been previously detected by molecular and serological methods in many areas [14, 15]. In this report, we describe two human SEOV cases diagnosed by both serologic and molecular detection in two hospitalized acute febrile illness with elevated liver enzyme without hemorrhagic manifestations and renal syndrome in Indonesia.

Case presentation

Methods and patients

Both patients are consented and enrolled as subjects during an observational study of Acute Febrile Illness Requiring Hospitalization (AFIRE) (NCT02763462). Clinical information and blood specimens were collected at enrollment, once during the 14–28 day period after enrollment, and at three months after enrollment. Patients who were discharged after the enrollment visit and failed to return to the hospitals for follow-up visits were seen at their homes, during which time the home environment could be casually observed. Patients’ diagnostic work-up at the hospitals (blood, respiratory, feces, or urine culture, and standard rapid diagnostic tests) and in the reference laboratory retrospectively (a panel of serological and molecular methods for the detection of bacteria and viruses) included selective testing for any culturable bacteria (i.e Salmonella typhi, Streptococcus pneumonia), Rickettsia spp., Orientia tsutsugamushi, Leptospira spp., dengue, chikungunya, Zika virus, and Human Immunodeficiency Virus (HIV). This study covered the cost of blood culture and other important diagnostic investigations based on the discretion of the attending clinicians at the hospitals, which may be used for clinical management.
Cases that were negative for previously described pathogens but demonstrated signs and symptoms of liver involvement or renal insufficiency were screened for hantavirus infection. Specimens from these subjects were tested for the expression of hantavirus IgM and IgG in acute and convalescent specimens (when available) by enzyme-linked immunosorbent assay (ELISA) using the Hantavirus IgM DxSelect™ and Hantavirus IgG DxSelect™ ELISA (Focus Diagnostics, Cypress, USA). Recent infection of hantavirus was confirmed if the IgM index value is > 1.10 in the acute samples and IgG index value is > 1.10 in the acute and/or convalescent samples. When serology result indicates recent hantavirus infection, acute buffy coat and plasma specimens were tested by nested reverse transcription polymerase chain reaction (nested RT-PCR) targeting the L segment of hantavirus [16] to confirm the etiology of acute febrile illness.
Viral RNA was firstly extracted from 140 μL of buffy coat and plasma-EDTA using the QIAamp® Viral RNA Mini kit (Qiagen GmbH, Hilden, Germany), according to the manufacturer’s instruction, and eluted in 60 μL of AVE elution buffer (Qiagen). RT-PCR was done in the Applied Biosystems Proflex PCR System (Thermo Fisher Scientific). The total reaction mixture volume is 25 μL, consisting of 20 μL mastermix (OneStep RT-PCR Kit (Qiagen), 1 μM each of HanL-F1 and HanL-R1 primer pair (Integrated DNA Technologies), nuclease-free water (Ambion)), and 5 μL RNA. The cycle condition of RT-PCR consists of reverse transcription (50o C 30 min), initial denaturation (94o C, 2 min), 35 cycles of denaturation (94o C, 15 s), primer annealing (52o C, 30 s), primer extension (72o C, 30 s), and followed by a final extension at 72o C for 10 min. The RT-PCR product was subsequently used as template for nested PCR in a 20 μL mastermix, consisting of 2X Go-Taq® Green Master Mix (Promega), 0.625 μM each of HanL-F2 and HanL-R2 primers (Integrated DNA Technologies), nuclease-free water (Ambion), and 2 μL of RT-PCR product. The nested PCR cycle condition consists of initial denaturation (95o C, 5 min), followed by 25 cycles of denaturation (94o C, 30 s), primer annealing (52o C, 30 s), primer extension (72o C, 25 s), and ended by a final extension at 72o C for 8 min. The nested PCR product is visualized on a 2% agarose gel electrophoresis and imaged using the GelDoc™ EZ Imager (Bio-Rad), where positive result appears as a 412-bp band.
Positive hantavirus specimens were further tested for species-specific SEOV RT-PCR targeting the N gene of the S segment, as described by Dekonenko et al [17] The cycle condition is similar with that of hantavirus RT-PCR, but the cycle threshold was increased to 40. The reaction mixture, but replacing the HanL-F1 and HanL-R1 primer pair with the SEO-HS1 and SEO-HS2 primer pair. RT-PCR product is also visualized on 2% agarose gel electrophoresis, where positive result appears as a 250-bp band. To confirm the identity of Seoul virus, SEOV RT-PCR product (250 bp) was sequenced using the similar RT-PCR primer pair (HS1 and HS2). The sequence was then compared to the NCBI nucleotide database using BLASTn (https://​blast.​ncbi.​nlm.​nih.​gov/​Blast.​cgi), where they aligned to nucleotides 338 through 587 of the SEOV N gene ORF. The genetic relationship was analyzed by neighbor-joining analysis using MEGA 7.0.2.
Both patients consented to have their clinical and laboratory data published and ethical clearance was approved by the IRBs of Dr. Soetomo General Hospital (192/Panke.KKE/VIII/2012) and the National Institute of Health and Research and Development (NIHRD), Ministry of Health, Indonesia (KE.01.05/EC/407/2012).

Cases

The detailed demography, clinical, and laboratory findings are presented in Table 1. The first patient was a 55-year-old housewife, who had no history of chronic disease, visited the emergency unit of Dr. Soetomo General Hospital in Surabaya on November 2, 2015, with a 4-day history of abrupt continuous fever. On admission, she presented with fever (38 °C), lethargy, abdominal-epigastric pain, nausea, and vomiting. On examination she was alert, blood pressure was 100/60 mmHg, and pulse rate was 82 beats per minute, no unremarkable findings on systemic examination. Laboratory results revealed leukopenia, lymphopenia, thrombocytopenia and increased liver enzymes. Blood cultures and Hepatitis B Surface Antigen (HBsAg) were negative. Two days after admission body temperature returned to normal but the platelet count was still below normal range (73 × 103/μL). Therefore, she was clinically diagnosed with dengue infection, treated with intravenous fluid Ringer’s lactate, and discharged 5-days after admission.
Table 1
Demography, clinical, and laboratory features both in hospital and reference laboratory
Patient
1
2
Age (years)
55
27
Gender
Female
Male
City
Surabaya
Jakarta
Dates of enrollment (days after fever onset)
03/11/2015 [4]
01/03/2016 [6]
Duration of hospital stay (days)
5
8
Symptoms and signs (at enrollment)
 Fever
Yes
Yes
 Anorexia
No
Yes
 Headache/Dizziness
No
Yes
 Decrease of consciousness
No
Yes
 Lethargy
Yes
No
 Abdominal/Epigastric pain
Yes
No
 Diarrhea
No
No
 Nausea
Yes
Yes
 Vomiting
Yes
Yes
 Retro orbital pain
Yes
No
 Arthralgia
No
Yes
 Jaundice
No
Yes
Laboratory results (normal value range) (at day 1 enrollment)
 Hematocrit (40–50%)
38.8
50.6
 White blood cells (3500–9000/μL)
3850
5790
 Neutrophils (39.8–70.5%)
73.2
79
 Lymphocyte (23.1–49.9%)
8.4
16
 Platelets (150–450 × 103/μL)
50,000
24,700
 AST (<  41 IU/L)
216
3900
 ALT (<  38 IU/L)
116
891
 Blood Urea Nitrogen (BUN) (10–23 mg/dL)
10
20.3
 Creatinine serum (0.5–1.2 mg/dL)
0.57
1.16
 C-Reactive protein (< 5 mg/dL)
ND
41.1
 Procalcitonin (< 0.5 ng/dL)
ND
5.98
Diagnostic work-up for other pathogens at reference laboratory PCR results at day 1 enrollment sample
 Dengue
Negative
Negative
 Chikungunya
Negative
Negative
 Zika
ND
Negative
 Hantavirus
Positive
Positive
 Seoul virus
Positive
Positive
Serological results (day 1 enrollment-convalescent (convalescent samples were taken 58 and 28 days after enrollment respectively for patient 1 and 2)
 Dengue IgM
Negative − Negative
Negative – Negative
 Dengue IgG
Positive − Positive
Negative − Negative
 Chikungunya IgG
ND − Negative
ND − Negative
 Salmonella IgM
Negative − Negative
Negative − Negative
 Salmonella IgG
Negative − Negative
Negative − Negative
 Leptospira IgM
Negative − Negative
Negative − Negative
 Leptospira IgG
Negative − Negative
Negative − Negative
 Hantavirus IgM
1:800–1:400
1:200–1:3200
 Hantavirus IgG
1:800–1:6400
1:400–1:12800
 Murine typhus IgG
ND − Negative
ND − Negative
 Scrub typhus (IgG)
ND − Negative
ND − Negative
 HIV antibody
Negative − Negative
Negative − Negative
ND: Not Done
The second patient was a 27-year-old working man who visited the emergency unit of Cipto Mangunkusumo Hospital in Jakarta on March 1, 2016, with a 6-day gradual continuous fever. On admission, he presented with fever (38.7 °C), decreased level of consciousness, jaundice, anorexia, nausea, vomiting, headache, dizziness, and arthralgia. His blood pressure was 140/90 mmHg, and pulse rate was 110 beats per minute. Hematology and biochemistry results revealed lymphopenia, thrombocytopenia, and a high level of transaminases. Blood cultures, dengue virus, hepatitis A, hepatitis C, cytomegalovirus (CMV), toxoplasma, rubella, herpes simplex virus 1 (HSV-1), HSV-2, and Salmonella work up were negative. During 8-days of hospitalization the transaminase levels decreased over time, although they remained above normal values (AST: 102 IU/L; ALT: 134 IU/L) until discharge. Despite a negative Salmonella Typhi IgM rapid test result, the patient was diagnosed as having typhoid fever based on clinical presentation and elevated inflammatory biomarkers C-reactive protein (CRP) and procalcitonin (Table 1). He received intravenous ceftriaxone 2 × 1 g according to Ministry of Health Republic of Indonesia clinical guidelines for suspected typhoid fever cases.
During follow-up visits, both patients had no remarkable symptoms and blood samples were taken. Rodent contact history was unknown for both patients upon enrollment, but during home visits we perceived that they lived in densely populated areas and close to open, rubbish-filled gutters where rodent infestations were present. However, these observations did not alter the diagnostic algorithm and were only associated with the cases after testing was completed. All serology tests were negative except for acute hantavirus infection (Table 1). The hantavirus IgM titer in patient 1 decreased in the convalescent specimen but the IgG titer increased. In patient 2, both IgM and IgG titers increased in the convalescent specimens. Since the convalescent samples were collected on different days after enrollment (days 58 and 28 for patients 1 and 2, respectively) (Additional file 1), the IgM kinetics were understandably different, with waning in patient 1 as expected. The acute samples were then tested positive for hantaviruses RNA and SEOV RNA. BLASTn analysis were performed on both samples, where sample from patient 2 was shown to be most similar (99.6% identity) to Seoul virus isolate Singapore/06(RN41) [18] (GenBank accession number GQ274944) and sample from patient 1 was shown to be most similar (98.4% identity) to Seoul virus strain Rn-DH27 (GenBank accession number GQ279393) at nucleotide 338–587 of the N gene ORF (Fig. 1).

Discussion and conclusions

Two acute febrile illness patients from two urban cities in Indonesia, Surabaya and Jakarta, were confirmed to have infections with SEOV. This finding may suggest that previous hantavirus cases from Indonesia and other Southeast Asia countries with similar clinical presentations (elevated liver enzymes, lymphopenia, thrombocytopenia with/out hemorrhagic manifestations and renal syndromes) were SEOV infections. Consistent with previous reports, both our patients had elevated liver enzyme and thrombocytopenia [2, 6, 9, 10, 19] . Clinical misdiagnoses occurred with the two reported patients due to the non-specific signs and symptoms of SEOV infection. In the first patient, clinicians provided a diagnosis of dengue fever as she had leukopenia, thrombocytopenia, and elevated liver enzymes. In the second patient, no pathogens were detected even though extensive testing was performed. Typhoid fever was provided as the diagnosis based on clinical observations of nausea, vomiting, icterus, and decrease of consciousness, all of which may be found in severe Salmonella typhi infections [20]. This report highlights the importance of considering SEOV infection in febrile patients with thrombocytopenia and elevation of liver enzymes despite the absence of hemorrhagic fever with renal syndrome. Because of clinically vague presentation of SEOV infection diagnostic capabilities at hospitals in Indonesia is needed.
Unlike previous hantavirus infection reports from Southeast Asian countries [3, 4] that could not determine the infected species the cases presented here were identified as SEOV infection by molecular method. The infrequent detection of SEOV by molecular method is likely due to the short duration of viremia and the limited number of cases tested [11]. Most cases of SEOV are associated with known rodent contacts [2, 6]. Although the history of rodent contact was unknown in both patients, our phylogenetic analysis result showed high similarity (98–99%) to SEOV in Kepulauan Seribu, Jakarta, Indonesia [14], and to SEOV circulating in the region [21] isolated from rodents. This finding supports previous reports on hantavirus infection in humans in Indonesia, and further identify that SEOV was the infecting species, in line with epizoonotic evidence that SEOV [12, 15] circulates in the local rodent population [14, 15].
In summary our cases illustrate the uncommon clinical presentation of SEOV infection which is the absence of hemorrhagic manifestation and renal syndrome. Increasing hospital diagnostic capacity on SEOV will be the main challenge in resource-limited setting such as Indonesia. Although the animal reservoirs are easily found anywhere in Indonesia, the true burden of SEOV illness is not known. The public health importance of rodent-borne pathogens such as SEOV urges for integrated epidemiological surveillance both in humans and rodents in Indonesia.

Acknowledgements

We would like to thank Pratiwi Sudarmono and Suharto for providing technical assistance and guidance. Suratno Lulut Ratnoglik and Akbar Fahmi for facilitating sample collection. Ungke Antonjaya, Deni Peppy R Butarbutar, and Dewi Lokida for help with sample processing and laboratory assistance.

Funding

This study was conducted by INA RESPOND, a collaborative research of NIHRD, Ministry of Health, Indonesia, and US-NIAID, NIH. This project has been funded in whole or in part with Federal funds from the NIAID, NIH, under contract Nos. HHSN261200800001E and HHSN261201500003I. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.

Availability of data and materials

The data supporting the conclusions of this article are included within this article. The sequence generated and analyzed for this report is available in the Genbank under the code MG561966 and MG 561967.
The study was approved by the IRBs of Dr. Soetomo General Hospital (192/Panke.KKE/VIII/2012) and the National Institute of Health and Research and Development (NIHRD), Ministry of Health, Indonesia (KE.01.05/EC/407/2012) and registered in clinicaltrials.​gov (NCT02763462). All participants provided written, informed consent to participate in the study.
Written informed consent was obtained from the patients for publication of this Case Report and any accompanying data (tables).

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
Literatur
1.
Zurück zum Zitat Lee HW, Baek LJ, Johnson KM. Isolation of Hantaan virus, the etiologic agent of Korean hemorrhagic fever, from wild urban rats. J infec dis. 1982;146(5):638–44.CrossRef Lee HW, Baek LJ, Johnson KM. Isolation of Hantaan virus, the etiologic agent of Korean hemorrhagic fever, from wild urban rats. J infec dis. 1982;146(5):638–44.CrossRef
2.
Zurück zum Zitat Zhang Y-Z, Dong X, Li X, Ma C, Xiong H-P, Yan G-J, et al. Seoul virus and hantavirus disease, Shenyang, People’s republic of China. Emerg Infect Dis. 2009;15(2):200–6.CrossRef Zhang Y-Z, Dong X, Li X, Ma C, Xiong H-P, Yan G-J, et al. Seoul virus and hantavirus disease, Shenyang, People’s republic of China. Emerg Infect Dis. 2009;15(2):200–6.CrossRef
3.
Zurück zum Zitat Lam SK, Chua KB, Myshrall T, Devi S, Zainal D, Afifi SA, et al. Serological evidence of hantavirus infections in Malaysia. Southeast Asian J Trop Med Public Health. 2001;32(4):809–13.PubMed Lam SK, Chua KB, Myshrall T, Devi S, Zainal D, Afifi SA, et al. Serological evidence of hantavirus infections in Malaysia. Southeast Asian J Trop Med Public Health. 2001;32(4):809–13.PubMed
4.
Zurück zum Zitat Wong TW, Chan YC, Joo YG, Lee HW, Lee PW, Yanagihara R. Hantavirus infections in humans and commensal rodents in Singapore. Trans R Soc Trop Med Hyg. 1989;83(2):248–51.CrossRef Wong TW, Chan YC, Joo YG, Lee HW, Lee PW, Yanagihara R. Hantavirus infections in humans and commensal rodents in Singapore. Trans R Soc Trop Med Hyg. 1989;83(2):248–51.CrossRef
5.
Zurück zum Zitat Kim YS, Ahn C, Han JS, Kim S, Lee JS, Lee PW. Hemorrhagic fever with renal syndrome caused by the Seoul virus. Nephron. 1995;71(4):419–27.CrossRef Kim YS, Ahn C, Han JS, Kim S, Lee JS, Lee PW. Hemorrhagic fever with renal syndrome caused by the Seoul virus. Nephron. 1995;71(4):419–27.CrossRef
6.
Zurück zum Zitat Reynes JM, Carli D, Bour JB, Boudjeltia S, Dewilde A, Gerbier G, et al. Seoul virus infection in humans, France, 2014-2016. Emerg Infect Dis. 2017;23(6):973–7.CrossRef Reynes JM, Carli D, Bour JB, Boudjeltia S, Dewilde A, Gerbier G, et al. Seoul virus infection in humans, France, 2014-2016. Emerg Infect Dis. 2017;23(6):973–7.CrossRef
7.
Zurück zum Zitat Mace G, Feyeux C, Mollard N, Chantegret C, Audia S, Rebibou JM, et al. Severe Seoul hantavirus infection in a pregnant woman, France, October 2012. Euro Surveillance. 2013;18(17):20464.PubMed Mace G, Feyeux C, Mollard N, Chantegret C, Audia S, Rebibou JM, et al. Severe Seoul hantavirus infection in a pregnant woman, France, October 2012. Euro Surveillance. 2013;18(17):20464.PubMed
8.
Zurück zum Zitat Jameson LJ, Taori SK, Atkinson B, Levick P, Featherstone CA, van der Burgt G, et al. Pet rats as a source of hantavirus in England and Wales, 2013. Euro Surveillance. 2013;18(9):20415.PubMed Jameson LJ, Taori SK, Atkinson B, Levick P, Featherstone CA, van der Burgt G, et al. Pet rats as a source of hantavirus in England and Wales, 2013. Euro Surveillance. 2013;18(9):20415.PubMed
9.
Zurück zum Zitat Woods C, Palekar R, Kim P, Blythe D, de Senarclens O, Feldman K, et al. Domestically acquired Seoul virus causing hemorrhagic fever with renal syndrome-Maryland, 2008. Clin Infect Dis. 2009;49(10):e109–12.CrossRef Woods C, Palekar R, Kim P, Blythe D, de Senarclens O, Feldman K, et al. Domestically acquired Seoul virus causing hemorrhagic fever with renal syndrome-Maryland, 2008. Clin Infect Dis. 2009;49(10):e109–12.CrossRef
10.
Zurück zum Zitat Nielsen CF, Sethi V, Petroll AE, Kazmierczak J, Erickson BR, Nichol ST, et al. Seoul virus infection in a Wisconsin patient with recent travel to China, march 2009: first documented case in the Midwestern United States. Am J Trop Med Hyg. 2010;83(6):1266–8.CrossRef Nielsen CF, Sethi V, Petroll AE, Kazmierczak J, Erickson BR, Nichol ST, et al. Seoul virus infection in a Wisconsin patient with recent travel to China, march 2009: first documented case in the Midwestern United States. Am J Trop Med Hyg. 2010;83(6):1266–8.CrossRef
11.
Zurück zum Zitat Mattar S, Guzmán C, Figueiredo LT. Diagnosis of hantavirus infection in humans. Expert Rev Anti-Infect Ther. 2015;13(8):939–46.CrossRef Mattar S, Guzmán C, Figueiredo LT. Diagnosis of hantavirus infection in humans. Expert Rev Anti-Infect Ther. 2015;13(8):939–46.CrossRef
12.
Zurück zum Zitat Groen J, Suharti C, Koraka P, van Gorp EC, Sutaryo J, Lundkvist A, et al. Serological evidence of human hantavirus infections in Indonesia. Infection. 2002;30(5):326–7.CrossRef Groen J, Suharti C, Koraka P, van Gorp EC, Sutaryo J, Lundkvist A, et al. Serological evidence of human hantavirus infections in Indonesia. Infection. 2002;30(5):326–7.CrossRef
14.
Zurück zum Zitat Ibrahim IN, Shimizu K, Yoshimatsu K, Yunianto A, Salwati E, Yasuda SP, et al. Epidemiology of hantavirus infection in Thousand Islands regency of Jakarta, Indonesia. J Vet Med Sci. 2013;75(8):1003–8.CrossRef Ibrahim IN, Shimizu K, Yoshimatsu K, Yunianto A, Salwati E, Yasuda SP, et al. Epidemiology of hantavirus infection in Thousand Islands regency of Jakarta, Indonesia. J Vet Med Sci. 2013;75(8):1003–8.CrossRef
15.
Zurück zum Zitat Kosasih H, Ibrahim IN, Wicaksana R, Alisjahbana B, Hoo Y, Yo IH, et al. Evidence of human hantavirus infection and zoonotic investigation of hantavirus prevalence in rodents in western Java, Indonesia. Vector Borne Zoonotic Dis. 2011;11(6):709–13.CrossRef Kosasih H, Ibrahim IN, Wicaksana R, Alisjahbana B, Hoo Y, Yo IH, et al. Evidence of human hantavirus infection and zoonotic investigation of hantavirus prevalence in rodents in western Java, Indonesia. Vector Borne Zoonotic Dis. 2011;11(6):709–13.CrossRef
16.
Zurück zum Zitat Klempa B, Fichet-Calvet E, Lecompte E, Auste B, Aniskin V, Meisel H, et al. Hantavirus in African wood mouse, Guinea. Emerg Infect Dis. 2006;12(5):838–40.CrossRef Klempa B, Fichet-Calvet E, Lecompte E, Auste B, Aniskin V, Meisel H, et al. Hantavirus in African wood mouse, Guinea. Emerg Infect Dis. 2006;12(5):838–40.CrossRef
17.
Zurück zum Zitat Dekonenko A, Ibrahim MS, Schmaljohn CS. A colorimetric PCR-enzyme immunoassay to identify hantaviruses. Clin Diagn Virol. 1997;8(2):113–21.CrossRef Dekonenko A, Ibrahim MS, Schmaljohn CS. A colorimetric PCR-enzyme immunoassay to identify hantaviruses. Clin Diagn Virol. 1997;8(2):113–21.CrossRef
18.
Zurück zum Zitat Johansson P, Yap G, Low H-T, Siew C-C, Kek R, Ng L-C, et al. Molecular characterization of two hantavirus strains from different rattus species in Singapore. Virol J. 2010;7(1):15.CrossRef Johansson P, Yap G, Low H-T, Siew C-C, Kek R, Ng L-C, et al. Molecular characterization of two hantavirus strains from different rattus species in Singapore. Virol J. 2010;7(1):15.CrossRef
19.
Zurück zum Zitat Park SC, Pyo HJ, Soe JB, Lee MS, Kim YH, Byun KS, et al. A clinical study of hemorrhagic fever with renal syndrome caused by Seoul virus infection. Korean J Intern Med. 1989;4(2):130–5.CrossRef Park SC, Pyo HJ, Soe JB, Lee MS, Kim YH, Byun KS, et al. A clinical study of hemorrhagic fever with renal syndrome caused by Seoul virus infection. Korean J Intern Med. 1989;4(2):130–5.CrossRef
20.
Zurück zum Zitat Parry CM, Thompson C, Vinh H, Chinh NT, Phuong le T, Ho VA, et al. Risk factors for the development of severe typhoid fever in Vietnam. BMC Infect Dis. 2014;14:73.CrossRef Parry CM, Thompson C, Vinh H, Chinh NT, Phuong le T, Ho VA, et al. Risk factors for the development of severe typhoid fever in Vietnam. BMC Infect Dis. 2014;14:73.CrossRef
21.
Zurück zum Zitat Zuo S-Q, Fang L-Q, Zhan L, Zhang P-H, Jiang J-F, Wang L-P, et al. Geo-spatial hotspots of hemorrhagic fever with renal syndrome and genetic characterization of Seoul variants in Beijing, China. PLoS Negl Trop Dis. 2011;5(1):e945.CrossRef Zuo S-Q, Fang L-Q, Zhan L, Zhang P-H, Jiang J-F, Wang L-P, et al. Geo-spatial hotspots of hemorrhagic fever with renal syndrome and genetic characterization of Seoul variants in Beijing, China. PLoS Negl Trop Dis. 2011;5(1):e945.CrossRef
Metadaten
Titel
Case report: two confirmed cases of human Seoul virus infections in Indonesia
verfasst von
Khie Chen Lie
Mochamad Helmi Aziz
Herman Kosasih
Aaron Neal
Caleb Leonardo Halim
Wahyu Nawang Wulan
Muhammad Karyana
Usman Hadi
Publikationsdatum
01.12.2018
Verlag
BioMed Central
Erschienen in
BMC Infectious Diseases / Ausgabe 1/2018
Elektronische ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-018-3482-1

Weitere Artikel der Ausgabe 1/2018

BMC Infectious Diseases 1/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.